patient is being treated. These cells and laboratory experiments 
will be performed in MSRB II, Room 3560, whereas the patient's 
clinical treatment will be taking place in the Clinical Research 
Center of The University of Michigan Medical Center Hospital. 
6.4 Repeated Treatment 
If no adverse side effects of the treatment are observed, 
repeated infusions will be considered at two-month intervals. 
Doses identical to the initial treatment regimen will be repeated 
with similar protocols and observation as described in Section 
6 . 1 . 
Recombinant DNA Research, Volume 18 
[ 19 ] 
